Immunotherapy is journal Science's 'breakthrough of the year' and Providence is on the case

January 06, 2014

The journal Science has identified immunotherapy as the Breakthrough of the Year, and although the accompanying article doesn’t name Providence Cancer Center specifically, the Portland-based center is a leader in the field.

Immunotherapy, which takes advantage of a patient’s own immune system to battle tumors, is the sole focus of Providence’s cancer research. Immunotherapy activates a patient’s immune system in a way that allows it to target and eradicate cancer cells, while minimizing damage to normal tissue.

Read more from the Portland Business Journal ›